Medicine and Dentistry
Patient
100%
Peptide
64%
Transplantation
43%
Gluconeogenesis
33%
Plasma
33%
Cingulate Sulcus
32%
Diseases
32%
Atrophy
32%
Intraparietal Sulcus
32%
Central Sulcus
32%
Bipolar Disorder
32%
Magnetic Resonance Imaging
32%
Glucose
29%
Lung
21%
Diabetes Mellitus
21%
Cardiovascular System
21%
Combination Therapy
21%
Weight Loss
21%
Hemoglobin A1c
21%
Dapagliflozin
21%
Kidney Graft
20%
Placebo
18%
Maturity Onset Diabetes of the Young
18%
Glucagon
12%
Insulin
12%
Evaluation Study
10%
Population
10%
Glucagon-Like Peptide-1 Agonist
10%
Assessment
10%
Blood
10%
Organ
10%
Liver
10%
Program Evaluation
10%
Adverse Drug Reaction
10%
Adult
10%
Glycemic
10%
Organ Transplantation
10%
Liver Graft
10%
Pancreatitis
10%
Follow up
10%
Antidiabetic Agent
10%
Kidney
10%
Insulin Treatment
10%
Urinary System
9%
Glucosuria
9%
Kidney Denervation
9%
Cotransporter
9%
Neuroscience
Receptor Agonists
64%
Peptide
64%
Inferior Frontal Sulcus
32%
Dapagliflozin
21%
Hemoglobin A1c
21%
Diabetes Mellitus
21%
Diabetes
21%
Placebo
18%
Glucagon-Like Peptide-1 Receptor Agonist
10%
Insulin Therapy
10%
Denervation
9%
Cotransporter
9%
Glucose
6%
Biochemistry, Genetics and Molecular Biology
Receptor Agonists
64%
Peptide
64%
Gluconeogenesis
33%
Weight
21%
Dapagliflozin
21%
Glucose Blood Level
15%
Solid
10%
Population
10%
Time
10%
Cotransporter
9%
Glucagon Blood Level
9%
Insulin Blood Level
9%
Glucose Urine Level
9%
Excretion
9%
Glucose
6%